Merit Medical Systems makes single-use medical devices and kits used mainly in interventional cardiology, radiology, endoscopy and related hospital procedures. Its portfolio covers access, drainage, inflation and embolotherapy products that clinicians use in cath labs and procedure rooms rather than large capital imaging systems. The company competes by combining broad disposable catalogs with custom procedure packs for hospitals and ambulatory centers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 355.4 | — | 30.1 | — |
| Q2 2025 | 382.5 | — | 32.6 | — |
| Q3 2025 | 384.2 | — | 27.8 | — |
| Q4 2025 | 393.9 | — | 38 | — |
| Q1 2026 | 381.9 | 7.5% | 41 | 36% |
| Q2 2026 | 418.8 | 9.5% | 38.8 | 19.1% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Laureate Education, Inc. (LAUR), Maase Inc. (MAAS), Selective Insurance Group, Inc. (SIGI), CG Oncology, Inc. (CGON), Rush Enterprises, Inc. (RUSHA), GRAIL, Inc. (GRAL)